A developing country response to Lavery <it>et al</it>. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?"
<p>Abstract</p> <p>Background</p> <p>A recent paper presents an argument and mechanism for the possible stopping of clinical trials early based on opportunity costs.</p> <p>Discussion</p> <p>Although we agree that the costs and opportunity costs...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-09-01
|
| Series: | BMC Medical Ethics |
| Online Access: | http://www.biomedcentral.com/1472-6939/10/16 |